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Abstract
HIV-associated neurocognitive disorder (HAND) remains a challenge despite antiretroviral therapy (ART), and has
been linked to monocyte/macrophage (M/M) migration to the brain. Due to the potential impact of T cell effector
mechanisms in eliminating activated/HIV-infected M/M, T cell activation may play a role in the development of
HAND. We sought to investigate the relationship between cognition and both CD8+ T cell activation (HLA-DR+/
CD38+) and HIV-specific CD8+ T cell responses at the time of HIV diagnosis and 12 months postinitiation of ART.
CD8+ T cell activation was increased in HAND compared to cognitive normal (NL) individuals and correlated
directly with plasma viral load and inversely with the cognitive status. In addition, Gag-specific cytolytic activity
(CD107a/b+) was decreased in HAND compared with NL individuals and correlated with their neurological testing,
suggesting a potential role of cytotoxic CD8+ T cells in the mechanism of HAND development.
Keywords: HIV-associated neurocognitive disorders, CD8+ T cell activation, HIV-specific cytolytic T cells
Antiretroviral therapy (ART) has greatly reduced theincidence of the most severe forms of HIV-associated
neurocognitive disorders (HAND), but milder forms of im-
pairment remain common. Investigations of HAND have
largely focused on monocytes/macrophages (Ms/Ms) due to
their susceptibility to infection and ability to cross the blood–
brain barrier once activated.1 Peripheral measures of M/M
frequency correlate with HAND symptoms and are predictive
of central nervous system (CNS) dysfunction in nonhuman
primates, leading many to conclude that M/M are critically
involved in CNS pathogenesis.2
M/M take their functional cues, in part, from the cognate
system, which is highly disrupted during chronic HIV in-
fection. Consequently, it can be hypothesized that T cells
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could play a larger role in CNS pathogenesis and protection.3
CD8+ T cell activation is associated with early neuronal
changes and strongly correlates with cerebrospinal fluid
(CSF) viral load in macaques that develop encephalitis later
during infection.4 More importantly, the depletion of CD8+ T
cells leads to more rapid progression of SIV-associated en-
cephalitis.5 Their inability to kill HIV-infected target cells
may lead to the unchecked transmigration of activated M/M
to the brain.
Although, CD8+ T cell frequency and functionality have
been associated with better overall clinical outcomes, their
impairment has not been specifically linked to the develop-
ment of HAND. Hence, we hypothesized that impaired
cognate CD8+ T cell responses may be involved in cognitive
impairment. In this study, we assessed the frequency of ac-
tivated CD8+ T cells and HIV-specific CD8+ T cell response
in HAND versus cognitively normal (NL) individuals at the
time of HIV diagnosis and 12 months post-ART initiation.
Fifty ART-naive HIV-infected volunteers (CD4 count
<350 cells/mm3) were enrolled into the SEARCH 007 study
(NCT00777426) at the Thai Red Cross AIDS Research
Centre in Bangkok, Thailand. Hepatitis C infection and illicit
drug use within the past 5 years as well as a positive illicit
drug screen were exclusion criteria (further information can
be found under clinicaltrials.gov). Based on clinical assess-
ment and neuropsychological testing battery, 23/50 were
characterized as cognitively normal (NL), and 27/50 with
HAND at time of HIV diagnosis. Following ART for 12
months, (zidovudine or stavudine, lamivudine, and nevir-
apine) 8/27 individuals with HAND were cognitively normal
in their assessments, while no participants in either group
regressed. Domain-specific standardized scores (NPZ) were
calculated as previously described and NPZglobal was defined
by aggregating the domain scores (NPZglobal at baseline: NL
0.12 vs. HAND -0.71; and at 12 months post-ART: NL 0.35
vs. HAND -0.86, p < .0001, respectively).6
At the time of diagnosis the median CD4 count in NL was
191 cells/mm3 (IQR 87–340) and 182 cells/mm3 (IQR 68–269;
p = .51) in HAND individuals, and after 12 months post-ART
initiation NL showed a median CD4 count of 393 cells/mm3
(IQR 249–548) and HAND individuals of 356 cells/mm3 (IQR
212–516; p = .34; Supplementary Table S1; Supplementary
Data are available online at www.liebertpub.com/aid). In ad-
dition, 10 matched HIV-seronegative healthy individuals (CO)
were enrolled (age range 24–46 years). Earlier, written signed
informed consent was obtained from all participants.
Frozen peripheral blood mononuclear cells (PBMCs)
were thawed and 1 · 106 PBMC were used for phenotypical
flow-cytometric assessment and in a standard intracellular
cytokine staining (ICS) assay for antigen-specific T cells as
previously described.7 PBMC were stained with Aqua Live/
Dead (Invitrogen) and the following antibodies: anti-CD3-
PE-Cy7 (Invitrogen), anti-CD4-ECD (Beckman Coulter),
anti-CD8-PerCP-Cy5.5, anti-HLA-DR-V450 and anti-
CD38-APC (BD Bioscience), anti-CD107a/b-FITC, anti-
CD14-AF700, anti-CD19-AF700 (BD Pharmingen), and
anti-IFNc-Pacific Blue (eBioscience). Cells were acquired
using a custom-build LSRII flowcytometer (BD Bioscience)
and analyzed using FlowJo (version 9.8 or higher; Tree Star;
Supplementary Fig. S1). A median of 99,800 (range 16,800–
163,000) CD3+ lymphocytes were acquired. A positive ICS
response was defined as at least 3 · background control and
‡0.05% gated positive cells. GraphPad Prism Version 6.0 or
higher was used for statistical analysis and presentation.
Statistical comparison between groups was performed using
the Mann–Whitney test and a Wilcoxon test for matched
samples, with p-values £.05 considered significant. For cor-
relation analysis, the Spearman rank test was used, and for the
effect size, a Cohen’s d test was used.
At the time of HIV diagnosis, NL and HAND individuals
showed a significantly higher frequency of activated CD8+ T
cells, indicated by the coexpression of HLA-DR and CD38
(CD8+DR+CD38+), compared to CO (NL 26.4% and HAND
41.8% vs. CO 2.8%; p < .001), which remained elevated at 12
months post-ART initiation (NL 7.2% and HAND 14.6% vs.
CO 2.8%; p < .001, Fig. 1A). However, we observed a sig-
nificant decrease in the frequency of CD8+DR+CD38+ T cells
in both NL and HAND individuals between time of diagnosis
and 12 months post-ART initiation from 26.4% to 7.2% and
41.8% to 14.6% ( p < .001), respectively. The frequency of
CD8+DR+CD38+ T cells in HAND individuals was higher
compared with NL individuals at both time points (baseline:
NL 26.4% vs. HAND 41.8%; 12 months post-ART: NL 7.2%
vs. HAND 14.6%), however, not statistically significant.
Similar trends were observed for CD4+DR+CD38+ T cells,
where the frequencies of NL and HAND individuals re-
mained elevated over those seen in the CO (baseline: NL:
6.6% and HAND: 20.3% vs. CO: 1.6%; p < .001; 12 months
post-ART: NL: 2.6% and HAND: 7.3% vs. CO: 1.6%;
p = .001 and p < .001, respectively, Fig. 1B). At the time of
diagnosis, the frequency of CD8+DR+CD38+ T cells, was
found in NL and HAND individuals to correlate directly with
plasma viral load (pVL) (r = 0.29, p = .05; Fig. 1C) and in-
directly with the NPZglobal score (r = -0.31, p = .01; Fig. 1D),
thus potentially linking CD8+ T cell activation, although
weakly, with viral replication and cognitive status. The effect
size between the two groups was moderate (Cohen’s d = 0.6)
supporting the outcome. However, there was no significant
correlation observed when NL and HAND individuals were
analyzed separately, due likely to restricted sample size
( p > .05, respectively; data not shown).
CD8+ T cell function was assessed using expression of
IFNc and the cytolytic marker CD107a/b. At the time of
diagnosis, in both groups, a slightly higher number of indi-
viduals expressed CD107a/b or IFNc upon Gag stimulation
compared with Env stimulation [CD107a/b: NL: Gag 17/23
(74%) vs. Env 13/23 (57%); HAND: Gag 17/22 (77%) vs.
Env 15/22 (68%); IFNc: NL: Gag 19/23 (83%) vs. Env 16/23
(70%); HAND: Gag 18/22 (82%) vs. Env 19/22 (86%)]. The
frequency of CD107a/b-expressing cytolytic Gag-specific
CD8+ T cells was significantly higher in NL compared with
HAND individuals at time of diagnosis (0.9% vs. 0.3%, re-
spectively; p = .006) and 12 months post-ART initiation
(0.4% vs. 0.1%, respectively; p = .003; Fig. 1E). The in-
creased frequency of cytolytic Gag-specific CD8+ T cells in
HAND individuals was not related to CD4 count at the time
of diagnosis or at 12 months post-ART initiation ( p > .05,
respectively; data not shown).
In addition, statistical significance remains when excluding
samples with persistent pVL at 12 months [NL (1/23 excluded)
compared with HAND (4/27 excluded) at time of diagnosis
(1.1% vs. 0.4%, respectively; p = .01) and 12 months post-
ART initiation (0.6% vs. 0.2%, respectively; p = .002; data not
shown)]. In contrast, there was no statistically significant















































































































































































































































































































































































































































































































































































































































































































































































































































































































difference in the frequency of Gag-specific IFNc-
expressing CD8+ T cells between the two groups at time of
diagnosis (0.7% vs. 0.3%, respectively; p = .06) or 12 months
post-ART initiation (0.2% vs. 0.1%, respectively; p = .11;
Fig. 1F). These findings are in accordance with observations
showing lower frequencies of cytolytic CD8+ T cells com-
pared with IFNc-expressing T cells in the CSF, and partly in
the periphery, of patients with HAND, suggesting failure of
ART to suppress HIV replication in the CSF contributing to
increased risk of HAND.8
Moreover, at the time of diagnosis the frequency of
CD107a/b-expressing CD8+ T cells correlated with the
NPZglobal score (r = 0.31, p = .05) indicating an impact of
cytolytic CD8+ T cells in the development of cognitive im-
pairment (Fig. 1G). In addition, the frequency of Gag-specific
CD107a/b-expressing CD8+ T cells at the time of diagnosis
correlated with the NPZscore 12 months post-ART initiation
(r = 0.34, p = .03; Fig. 1H). The statistical significance of the
reported correlations is consistent with those observed by
other studies between neurocognitive impairment and HIV
disease biomarkers.9 However, 12 months following ART-
initiation, a significant decrease in the frequency of CD107a/
b- and IFNc-expressing Gag-specific CD8+ T cells was ob-
served compared to time of diagnosis in NL (CD107a/b:
0.9% vs. 0.4%, p < .001, IFNc: 0.7% vs. 0.2%, p < .001) as
well as in HAND individuals (CD107a/b: 0.4% vs. 0.1%,
p = .002, IFNc: 0.3% vs. 0.1%, p = .01; Fig. 1E, F), potentially
due to reduction of pVL upon ART initiation.
Although ART reduces the more severe forms of HAND,
the etiology of mild to moderate cognitive impairment de-
spite ART remains unclear but likely also involves mecha-
nisms such as M/M infiltration/accumulation in the brain.
There is growing evidence that multiple factors are involved
in the development and persistence of cognitive dysfunction
despite ART.1 A decreased CD4/CD8 ratio in both peripheral
blood and the CSF strongly correlated with the grade of
cognitive impairment in HIV patients on ART, highlighting
the potential importance of T cells.10 In addition, the im-
portance of cytolytic CD8+ T cells has been highlighted and
their absence in the CSF potentially linked to the failure of
ART to suppress HIV replication within the CNS.8
The aim of the present study was to evaluate the potential
role of peripheral CD8+ T cells in the development of cog-
nitive impairment. Our findings support a previous study10
showing a trend toward higher immune activation of CD8+
and CD4+ T cells in HAND compared with NL individuals.
Activation status of CD8+, but not CD4+T cells inversely
correlated with cognitive status, which potentially could link
ongoing immune activation and neurological injury. It is
known, that ongoing immune activation is a strong predictor
of HIV disease progression, but could also serve as a marker
for the development of cognitive dysfunction.10
In addition, impairment of cytolytic CD8+ T cells has been
shown to correlate with HIV disease progression.8,11 In vitro
studies have demonstrated, that cytolytic CD8+ T cells both
suppress and kill HIV replication in macrophages.12 We
observed, that Gag-specific cytolytic CD8+ T cell responses
(CD107a/b-expression) mounted in HAND individuals were
significantly lower compared to NL individuals at the time of
diagnosis and 12 months posttreatment, correlating with the
NPZscore. These findings suggest a more impaired cytolytic
immune response in HAND individuals, which could con-
tribute to a failure to prevent trafficking of activated/infected
M/M to the brain and subsequently lead to the development
of cognitive impairment. In contrast, there was no significant
difference in the frequency of IFNc-expressing CD8+ T cells
observed between HAND and NL individuals at any time.
However, this was a relatively small, but well controlled,
study, and hence, it was not within the scope of this study to
address the full spectrum of relevant considerations such as
the impact of early initiated ART on neurological impairment
or interrogate T cell responses in the CSF. Consequently,
further studies are necessary, that include a larger sample size
to confirm and expand on those findings and to elucidate the
level of CD8+ T cell impairment across compartments. In-
clusion of exhaustion markers such as PD-1 or Tim-311 will
also be valuable to determine whether these negative check-
points moderate M/M trafficking into the brain.
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